Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Immune Dysregulation in Patients With Sporadic Inclusion Body Myositis (s-IBM)

NCT00030212 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.

NCT NCT00030212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00030212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Immune Dysregulation in Patients With Sporadic Inclusion Body Myositis (s-IBM)
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Phase
Observational
Overall status
Completed
Start date
February 4, 2002
Completion date
December 10, 2007
Enrollment
80
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

inclusion body, myositis, sporadic